Archer Dividend Growth Fund ARDGX

Morningstar Medalist Rating
  • NAV / 1-Day Return$33.73  /  −1.11%
  • Fund Size$36.1M
  • Adjusted Expense Ratio0.990%
  • Net Expense Ratio0.980%
  • Fee Level: DistributionAbove Average
  • Share Class TypeNo Load
  • Morningstar CategoryLarge Value
  • Equity Style Box (Funds)Mid Value
  • Minimum Initial Investment$2,500
  • Investment StatusOpen
  • TTM Yield2.32%
  • Turnover Ratio18%

Morningstar’s Analysis ARDGX

Will ARDGX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

Archer Dividend Growth holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings ARDGX

  • Current Portfolio Date
  • Equity Holdings—
  • Bond Holdings—
  • Other Holdings—
  • % Assets in Top 10 Holdings26.9
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Cash & Cash Equivalents

5.612M
Cash and Equivalents

JPMorgan Chase & Co

3.201M
Financial Services

Gilead Sciences Inc

2.951M
Healthcare

Broadcom Inc

2.75962,884
Technology

Merck & Co Inc

2.70947,880
Healthcare

Regions Financial Corp

2.69944,208
Financial Services

Citizens Financial Group Inc

2.65929,745
Financial Services

Johnson & Johnson

2.64926,487
Healthcare

Coca-Cola Femsa SAB de CV ADR

2.49872,606
Consumer Defensive

Pfizer Inc

2.45859,492
Healthcare

Sponsor Center